BioGeneration Ventures — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Azafarosazafaros.comSeed · Jul 2018✓ verified

Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.

BiotechDeep TechHealthtechMedical DevicesLeiden, NL

Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)

Co-investorsBioMedPartners Forbion Jeito Capital Pictet Group Seroba Life Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.